Omeros' stock offering; Ophthotech's disappointing results from wet AMD trial; …
Below is a three month price history chart comparing the stock performance of REGN vs. VOD: According to the ETF Finder at ETF Channel, REGN and VOD collectively make up 3.18% of the First Trust NASDAQ-100 Ex-Technology …
(NASDAQ:MXIM) shares with value of $1.16 million were sold by KIDDOO BRUCE …
Neuberger Berman Group Llc decreased Regeneron Pharmaceuticals Inc (NASDAQ ... Commerce Bancorporation invested in 35,775 shares or 0.03% of the stock. Staunton Library expect large numbers at eclipse party People are …
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) SVP Robert E. Landry sold 526 shares of the stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $472.19, for a total value of …
Breeze4mon
REGN) saw its share price fall 2.5% in pre-market trading, after it announced a Phase III trial failure for its investigational drug for respiratory syncytial virus …
Regeneron reported Friday that its sales rose ahead of expectations ... Register now to create your own custom streaming stock watchlist. NYSE, AMEX, and …
Known for its strong R&D engine and its string of successes, Regeneron has long been an investor darling. That's why the company's stock price were largely unaffected after the big biotech announced it would be dropping development of one …
Shares of Biogen have gained 11.5% so far this year, and while that's better than the S&P 500's 10.3% rise during the same, its lagged the iShares Nasdaq Biotechnology ETF's (IBB) 17%, while Celgene (CELG), Amgen (AMGN), and …
The stock decreased 0.94% or $0.69 during the last trading session ... Inc. Douglass Winthrop Limited Liability Company holds 0.02% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 775 shares. This is a positive …